Elizabeth Whittington

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.

President signs genetic anti-discrimination bill.

Adult cancers are biologically different from childhood cancer, resulting in different treatments and different success rates.

Oral contraceptives decrease incidence of ovarian cancer.

Dr. Len answers the question: “Does discontinuing hormone replacement therapy increase risk of breast cancer?”

A soldier returns home to help his sister through leukemia treatment.

A gynecologic oncologist and her patient form an unusual friendship.

Edward Kennedy and Sydney Pollack.

Childhood cancer survivors are at higher risk for heart disease.

Hawaiian retreat offers relaxation.

Patient website gets a makeover.

Two more states guarantee colon screening coverage.

Discussion of new drugs for CLL and to relieve constipation.

The FDA approves Avastin for breast cancer and a lung cancer trial involving Nexavar shows no survival benefit.

Strategies for preventing cancer in people with a genetic predisposition.

Organizations and institutions offer palliative care information and services to patients.

Advocates push for clinical trial insurance coverage.

Dan Fogelberg and Stephen Stills.

We Can Weekend for families.

Twins' blood may explain how childhood leukemia develops.

Highlighting survivors' artistic works.

Risk varies for BRCA carriers.

Breast cancer risk tool updated for African-Americans.

Lu Sipos' Chemo Duck comforts childhood cancer patients.

The American Society of Clinical Oncology (ASCO) 2007 top Clinical Cancer Advances: Major Research Advances in Cancer Treatment, Prevention, and Screening saw advances in liver cancer, better screening methods for breast cancer, and the first vaccine to prevent cervical cancer—each advancement in prevention, screening, and treatment brings researchers one step closer to improving quality care for all people affected by cancer.

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.

The number of women choosing aggressive breast cancer surgery has doubled in the past decade.

Peter Boyle and Forest Whitaker.

Colorectal Cancer Coalition (C3) hosts second annual event in Washington DC.